ES2055902T3 - Composiciones farmaceuticas de proteinas activadoras del plasminogeno. - Google Patents
Composiciones farmaceuticas de proteinas activadoras del plasminogeno.Info
- Publication number
- ES2055902T3 ES2055902T3 ES90903109T ES90903109T ES2055902T3 ES 2055902 T3 ES2055902 T3 ES 2055902T3 ES 90903109 T ES90903109 T ES 90903109T ES 90903109 T ES90903109 T ES 90903109T ES 2055902 T3 ES2055902 T3 ES 2055902T3
- Authority
- ES
- Spain
- Prior art keywords
- pharmaceutical compositions
- activating proteins
- plasminogen activating
- plasminogen
- proteins
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 102000013566 Plasminogen Human genes 0.000 title 1
- 108010051456 Plasminogen Proteins 0.000 title 1
- 230000003213 activating effect Effects 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 102000004169 proteins and genes Human genes 0.000 title 1
- 108090000623 proteins and genes Proteins 0.000 title 1
- 239000007924 injection Substances 0.000 abstract 1
- 238000001990 intravenous administration Methods 0.000 abstract 1
- 239000000546 pharmaceutical excipient Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
- A61K38/49—Urokinase; Tissue plasminogen activator
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Biomedical Technology (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Abstract
SE PRESENTAN FORMULAS FARMACEUTICAS DE INYECCIONES DE BOLO INTRAVENOSAS QUE PROPORCIONAN DELTAFE1X EN CONCENTRACIONES RELATIVAMENTE ALTAS A BAJAS CONCENTRACIONES DE EXCIPIENTES.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US07/302,846 US4980165A (en) | 1989-01-27 | 1989-01-27 | Pharmaceutical formulations of plasminogen activator proteins |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2055902T3 true ES2055902T3 (es) | 1994-09-01 |
Family
ID=23169461
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES90903109T Expired - Lifetime ES2055902T3 (es) | 1989-01-27 | 1990-01-26 | Composiciones farmaceuticas de proteinas activadoras del plasminogeno. |
Country Status (9)
Country | Link |
---|---|
US (1) | US4980165A (es) |
EP (1) | EP0455725B1 (es) |
JP (1) | JP2636499B2 (es) |
AT (1) | ATE104863T1 (es) |
CA (1) | CA2045562A1 (es) |
DE (1) | DE69008513T2 (es) |
DK (1) | DK0455725T3 (es) |
ES (1) | ES2055902T3 (es) |
WO (1) | WO1990008557A1 (es) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5270198A (en) * | 1988-05-20 | 1993-12-14 | Genentech, Inc. | DNA molecules encoding variants of tissue plasminogen activators, vectors, and host cells |
US5262170A (en) * | 1988-09-02 | 1993-11-16 | Genentech, Inc. | Tissue plasminogen activator having zymogenic or fibrin specific properties and substituted at amino acid positions 296-299, DNA molecules encoding them, vectors, and host cells |
US5714145A (en) * | 1988-09-02 | 1998-02-03 | Genentech, Inc. | Tissue plasminogen activator having zymogenic or fibrin specific properties |
JP2520975B2 (ja) * | 1989-09-21 | 1996-07-31 | 三井東圧化学株式会社 | 組織プラスミノ―ゲンアクチベ―タ―若しくはその誘導体を含有する血栓溶解剤 |
DE3942141A1 (de) * | 1989-12-20 | 1991-06-27 | Boehringer Mannheim Gmbh | K2p pro-stabilisierung |
DE3942143A1 (de) * | 1989-12-20 | 1991-06-27 | Boehringer Mannheim Gmbh | T-pa pro stabilisierung |
DE3942142A1 (de) * | 1989-12-20 | 1991-06-27 | Boehringer Mannheim Gmbh | Stabilisierung von glykosyliertem t-pa |
DE3942145A1 (de) * | 1989-12-20 | 1991-06-27 | Boehringer Mannheim Gmbh | T-pa-solubilisierung |
US5366730A (en) * | 1989-12-20 | 1994-11-22 | Boehringer Mannheim Gmbh | Stabilized compositions having human tissue type plasminogen activator enzymatic activity |
ES2082465T3 (es) * | 1991-04-16 | 1996-03-16 | Boehringer Mannheim Gmbh | Unidad farmaceutica de envasado que contiene activadores de plasminogeno para la administracion multiple de bolos. |
DK0643772T3 (da) * | 1992-06-03 | 1998-02-02 | Genentech Inc | Glycosyleringsvarianter af vævsplasminogenaktivator med forbedrede terapeutiske egenskaber |
US5510330A (en) * | 1994-03-25 | 1996-04-23 | Boehringer Mannheim Gmbh | Combinations of thrombolytically active proteins and non-heparin anticoagulants, and uses thereof. |
KR100236393B1 (ko) * | 1996-02-02 | 1999-12-15 | 나까니시 히로유끼 | 사람성장호르몬을 함유하는 의약제제 |
WO2008152764A1 (ja) | 2007-06-14 | 2008-12-18 | Pola Pharma Inc. | 医薬組成物 |
DE102007057543A1 (de) * | 2007-11-29 | 2009-06-04 | Merck Patent Gmbh | a-Aminosäurederivate zur Löslichkeitsverbesserung |
US8980610B2 (en) | 2008-11-20 | 2015-03-17 | Biogen Idec Ma Inc. | Arginine inactivation of viruses |
WO2014159659A1 (en) | 2013-03-12 | 2014-10-02 | Stein Emily A | Dental composition comprising chelator and base |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS54147916A (en) * | 1978-05-12 | 1979-11-19 | Sumitomo Chem Co Ltd | Preparation of urokinase injection |
DE3203775A1 (de) * | 1982-02-04 | 1983-08-11 | Behringwerke Ag, 3550 Marburg | Fibrinogenzubereitung, verfahen zu ihrer herstellungund ihre verwendung |
JPS5951220A (ja) * | 1982-08-02 | 1984-03-24 | Asahi Chem Ind Co Ltd | 新規なプラスミノ−ゲン・アクチベ−タ−およびその製法ならびにこれを含有する薬剤 |
HU200695B (en) * | 1985-05-28 | 1990-08-28 | Wellcome Found | Process for producing stable pharmaceutical compositions comprising tissural plasminogene activator |
US4929444A (en) * | 1985-05-28 | 1990-05-29 | Burroughs Wellcome Co. | Low pH pharmaceutical formulation containing t-PA |
ZW14486A1 (en) * | 1985-07-29 | 1986-10-22 | Smithkline Beckman Corp | Pharmaceutical dosage unit |
WO1987001389A1 (en) * | 1985-09-06 | 1987-03-12 | Codon | Methods for the recovery of tissue plasminogen activator |
JPH0672105B2 (ja) * | 1985-10-02 | 1994-09-14 | 持田製薬株式会社 | 血栓溶解剤及びその製法 |
US4777043A (en) * | 1985-12-17 | 1988-10-11 | Genentech, Inc. | Stabilized human tissue plasminogen activator compositions |
US4857320A (en) * | 1987-02-19 | 1989-08-15 | Monsanto Company | Method of enhancing the solubility of tissue plasminogen activator |
DE3718889A1 (de) * | 1987-06-05 | 1988-12-22 | Behringwerke Ag | Verfahren zur herstellung einer loesung hoher spezifischer volumenaktivitaet von einem protein mit gewebe-plasminogenaktivator (t-pa)-aktivitaet, loesung, enthaltend protein mit t-pa-aktivitaet und verwendung der loesung in der human- und veterinaermedizin |
JP2708749B2 (ja) * | 1987-08-10 | 1998-02-04 | エーザイ株式会社 | 修飾型tPA含有注射用組成物 |
US4898826A (en) * | 1987-12-10 | 1990-02-06 | Invitron Corporation | Method to solubilize tissue plasminogen activator |
-
1989
- 1989-01-27 US US07/302,846 patent/US4980165A/en not_active Expired - Lifetime
-
1990
- 1990-01-26 AT AT9090903109T patent/ATE104863T1/de not_active IP Right Cessation
- 1990-01-26 EP EP90903109A patent/EP0455725B1/en not_active Expired - Lifetime
- 1990-01-26 DK DK90903109.8T patent/DK0455725T3/da active
- 1990-01-26 WO PCT/US1990/000467 patent/WO1990008557A1/en active IP Right Grant
- 1990-01-26 JP JP2503262A patent/JP2636499B2/ja not_active Expired - Fee Related
- 1990-01-26 ES ES90903109T patent/ES2055902T3/es not_active Expired - Lifetime
- 1990-01-26 CA CA002045562A patent/CA2045562A1/en not_active Abandoned
- 1990-01-26 DE DE69008513T patent/DE69008513T2/de not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
EP0455725B1 (en) | 1994-04-27 |
CA2045562A1 (en) | 1990-07-28 |
WO1990008557A1 (en) | 1990-08-09 |
US4980165A (en) | 1990-12-25 |
DE69008513T2 (de) | 1994-11-24 |
EP0455725A1 (en) | 1991-11-13 |
DK0455725T3 (da) | 1994-09-05 |
JPH04503070A (ja) | 1992-06-04 |
DE69008513D1 (de) | 1994-06-01 |
ATE104863T1 (de) | 1994-05-15 |
JP2636499B2 (ja) | 1997-07-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2055902T3 (es) | Composiciones farmaceuticas de proteinas activadoras del plasminogeno. | |
SE8402560L (sv) | Farmaceutisk komposition | |
FI863664A (fi) | Emulsionskompositioner foer dosering av i vatten svaorloesliga joniserbara hydrofoba laekemedel. | |
MX171191B (es) | Composiciones farmaceuticas de glipizida | |
ES2119411T5 (es) | Combinaciones de proteinas y anticoagulantes tromboliticamente activos, y usos de los mismos. | |
FI863652A (fi) | 7-isopropoxiisflavoninklusionskomplex bildat med cyklodextrin och ett foerfarande foer dess framstaellning. | |
DK0671912T3 (da) | Injicerbare præparater baseret på taxanderivater | |
PT734737E (pt) | Administracao de particulas de agentes terapeuticos em po | |
TR199700574T1 (xx) | Molek�ler �aperon �retiminin haz�rlanmas� i�in yararl� hidroksilamin t�revleri ve bu t�revlerin haz�rlanmas�. | |
KR890700359A (ko) | 안정한 인터페론 복합체 | |
BR0209777A (pt) | Formulações lìquidas estáveis | |
DE69521693D1 (de) | Taxanderivate enthaltende arzneizubereitungen | |
SE8600632D0 (sv) | Novel pharmaceutical composition | |
TR199800717T2 (xx) | Amyotrofik lateral skleroz tedavisine y�nelik ila� haz�rlamak i�in | |
KR900700124A (ko) | 흑색종 치료용 il-2 및 dtic의 치료 조성물 | |
DK148890D0 (da) | Farmaceutisk praeparat | |
NO20042100L (no) | Fremgangsmate for administrering av et tymosinalfa 1-peptid | |
ES2160582T3 (es) | Capsula dura de ocfosfato de citarabina. | |
SE8703788L (sv) | Farmaceutiska kompositioner och anvendning av dessa | |
GB1226773A (es) | ||
BG100647A (en) | Perenteral medicamentous form based on avremectine and ivermectine | |
BG28243A3 (en) | Incecticide means | |
FR2453153A1 (fr) | Nouveau derive de dehydroproline, sa preparation et son application comme medicament |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG2A | Definitive protection |
Ref document number: 455725 Country of ref document: ES |